Life Sciences Action Summit
Building the Life Science industry in the Research Corridor & Addressing Our Nation’s Need for Readiness and Response
Fargo, North Dakota
February 19, 2010
Interested in sponsoring? Sign up online or contact Matthew Leiphon, 701-775-3354
Life Sciences Action Summit Featured Sessions
Summit Features High-Impact Keynote Speakers
Hear from prominent, nationally-recognized experts about the nation’s most pressing challenges related to biodefense and leading-edge initiatives and ventures to address these challenges:
- Gregory A. Poland, M.D., Director, Mayo Clinic’s Vaccine Research Group
- G. Steven Burrill, Chief Executive Officer, Burrill & Company (a San Francisco-based life sciences merchant bank)
- Dr Michael Kurilla, Director, Office of BioDefense Research Affairs, US Department of Health and Human Services
Sessions Focus on Growing Companies and the Industry:
The summit will feature two panel sessions on building life sciences companies and building the life sciences industry here in the Red River region. Confirmed participants include:
- Tim Cooke, CEO, Novadigm
- Michael Chambers, CEO, Aldevron
- Dennis Anderson, Associate Vice President, Business Development and Industrial Relations, North Dakota State University
- Robert Bargatze, Chief Scientific Officer and Founder of Ligocyte Pharmaceuticals
- John Langstaff, President and CEO, Cangene Corporation
- James Carlson, Pharm. D., JDC Management
- Barry Milavetz, Ph.D., Associate Vice President for Research, University of North Dakota
- Kermit Nash, Principal, Gray Plant Mooty, Entrepreneurial Services group